药品名称 VBC101-F11 药品类别 创新药; 生物; 抗体; 蛋白激酶; 受体酪氨酸激酶; 偶联药物 靶点 hepatocyte growth factor receptor (HGFR, c-Met); epidermal growth factor receptor (EGFR) 作用机制 anti-EGFR/c-Met抗体偶联药物; anti-EGFR/c-Met双特异性抗体 药品简介 -- 研发机构 橙帆医药 最高...
Therefore, the interplay between EGFR and cMet, coupled with their differential expression in tumors versus normal tissue substantiates the rationale for a bispecific approach that targets both receptors to enhance tumor specificity.VBC101-F11 is a bispecific anti-EGFR/cMet ADC engineered to deliver ...